Jennifer J Griggs, MD, MPH, FACP, FASCO

 Jennifer Griggs
Professor of Internal Medicine, Medical School
Professor of Health Management and Policy, School of Public Health
University of Michigan
North Campus Research Complex
2800 Plymouth Rd, Building 14, G226
Ann Arbor, MI 48109-2800
[email protected]
Available to mentor
Jennifer J Griggs, MD, MPH, FACP, FASCO
Jennifer Griggs
Professor
  • Center Memberships
  • Recent Publications

  • Manage Your Profile

    • Center Memberships
    • Center Member
      Rogel Cancer Center
    • Center Member
      Institute for Healthcare Policy and Innovation
    • Center Member
      Global REACH

    Recent Publications

     See All Publications
    • Proceeding / Abstract / Poster
      Associations between interpersonal violence and cancer risk factors for transgender and cisgender people.
      Alpert AB, Sayegh SJ, Strawderman MS, Cunliffe S, Cupertino AP, Griggs JJ, Cerulli C. JOURNAL OF CLINICAL ONCOLOGY, 2022 40 (16):
      PMID: 5B6LX
    • Proceeding / Abstract / Poster
      Cancer risk factors and cancer in transgender versus cisgender people: Real-world data from a tertiary health care institution.
      Alpert AB, Sayegh SJ, Strawderman MS, Cunliffe S, Cupertino AP, Cerulli C, Griggs JJ. JOURNAL OF CLINICAL ONCOLOGY, 2022 40 (16):
      PMID: 5B6LX
    • Proceeding / Abstract / Poster
      Family history assessment to identify patients at risk for hereditary cancer syndromes in community oncology practices.
      Austin S, Hanson E, Griggs JJ, Resnicow K, Stoffel EM. JOURNAL OF CLINICAL ONCOLOGY, 2022 40 (16): E18735 - E18735.
      PMID: 5B6LX
    • Proceeding / Abstract / Poster
      Oncologist knowledge of cost of genetic testing.
      Weiner S, Austin S, Carr G, Kidwell KM, Resnicow K, Stoffel EM, Griggs JJ. JOURNAL OF CLINICAL ONCOLOGY, 2022 40 (16):
      PMID: 5B6LX
    • Proceeding / Abstract / Poster
      Obesity and Angiolymphatic Invasion in Primary Breast Cancer.
      Griggs J, Gillespie E, Hanauer D, Jagielski C, Sabel M, Sorbero M. Cancer Research, 2017 Aug 31; 69 (24_Supplement): 5151 - 5151. DOI:10.1158/0008-5472.sabcs-09-5151
    • Journal Article
      The landscape of chemotherapy modifications among women treated for stage I–IIIA breast cancer
      Bhimani J, O’Connell K, Blinder VS, Burganowski R, Ergas IJ, Gallagher GB, Griggs JJ, Heon N, Jinna S, Kolevska T, Kotsurovskyy Y, Kroenke CH, Laurent CA, Liu R, Nakata KG, Persaud S, Roh JM, Valice E, Bandera EV, Bowles EJA, Kushi LH, Kantor ED. Cancer, 2026 Mar 15; 132 (6): DOI:10.1002/cncr.70318
    • Journal Article
      Clinician- and facility-level factors associated with chemotherapy dose reductions in stages I-IIIA breast cancer.
      Sampathkumar Y, Zakaria Z, O'Connell K, Bhimani J, Blinder VS, Burganowski R, Ergas IJ, Gallagher GB, Griggs JJ, Heon N, Kolevska T, Kotsurovskyy Y, Kroenke CH, Laurent CA, Liu R, Monroy-Iglesias MJ, Nakata KG, Persaud S, Roh JM, Tabatabai S, Valice E, Wang P, Bandera EV, Aiello Bowles EJ, Kushi LH, Kantor ED. J Natl Cancer Inst, 2026 Mar 4; DOI:10.1093/jnci/djag063
      PMID: 41782330
    • Journal Article
      Initial chemotherapy dose reductions and subsequent treatment delivery in stage I–IIIA breast cancer
      Monroy-Iglesias MJ, O’Connell K, Bhimani J, Blinder VS, Burganowski-Doud RP, Ergas IJ, Gallagher GB, Griggs JJ, Heon N, Kolevska T, Kotsurovskyy Y, Kroenke CH, Laurent CA, Liu R, Nakata KG, Persaud S, Roh JM, Sampathkumar Y, Tabatabai S, Valice E, Wang P, Aiello Bowles EJ, Bandera EV, Kushi LH, Kantor ED. Cancer, 2026 Mar 1; 132 (5): DOI:10.1002/cncr.70294
      PMID: 41732900